Repare Therapeutics (RPTX) PT Lowered to $4 at Stifel; 'Removing PROC Lowers TP'

December 13, 2024 9:24 AM EST Send to a Friend
Stifel analyst Benjamin J. Burnett lowered the price target on Repare Therapeutics (NASDAQ: RPTX) to $4.00 (from $9.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login